C. Gao

发表

Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization.

M. Mack, P. Serruys, R. D. de Winter, 2020, European journal of preventive cardiology.

Periprocedural Outcomes Associated With Use of a Left Atrial Appendage Occlusion Device in China

P. Serruys, S. Garg, D. Holmes, 2022, JAMA network open.

10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.

M. Mack, P. Serruys, F. Mohr, 2021, Journal of the American College of Cardiology.

Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study

D. van Klaveren, M. Mack, P. Serruys, 2021, Clinical Research in Cardiology.

10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.

M. Mack, P. Serruys, R. D. de Winter, 2021, JACC. Cardiovascular interventions.

Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.

M. Mack, P. Serruys, F. Mohr, 2020, Journal of the American College of Cardiology.

Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.

D. van Klaveren, M. Mack, P. Serruys, 2020, Journal of the American College of Cardiology.

Predicted and Observed Mortality at 10-Years in Patients With Bifurcation Lesions in the SYNTAX Trial.

D. van Klaveren, M. Mack, P. Serruys, 2022, JACC. Cardiovascular interventions.

Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).

M. Mack, P. Serruys, J. Wykrzykowska, 2021, The American journal of cardiology.

Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization

M. Mack, J. Spertus, P. Serruys, 2022, Circulation.

Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.

P. Serruys, H. Thiele, A. Baumbach, 2020, American heart journal.

Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

J. Reiber, P. Serruys, A. Íñiguez, 2022, American heart journal.

Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.

M. Mack, P. Serruys, F. Mohr, 2021, Journal of the American College of Cardiology.

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

P. Serruys, J. McEvoy, W. Wijns, 2020, European heart journal.

Human mesenchymal stem cells encapsulated-coacervated photoluminescent nanodots layered bioactive chitosan/collagen hydrogel matrices to indorse cardiac healing after acute myocardial infarction.

Rui Guo, Chao Gao, Wen-yi Guo, 2020, Journal of photochemistry and photobiology. B, Biology.

Comparison of outcomes between novel oral anticoagulants and warfarin monotherapy in patients with left atrial appendage closure: A systematic review and meta-analysis

C. Gao, L. Tao, Bing Sun, 2022, Frontiers in Cardiovascular Medicine.

Comparative Quantitative Aortographic Assessment of Regurgitation in Patients Treated With VitaFlow Transcatheter Heart Valve vs. Other Self-Expanding Systems

P. Serruys, W. Wijns, H. Kawashima, 2022, Frontiers in Cardiovascular Medicine.

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

P. Serruys, J. Wykrzykowska, J. Piek, 2020, Frontiers in Cardiovascular Medicine.

Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Expert opinion on drug delivery.

External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial

P. Serruys, S. Windecker, M. Valgimigli, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond

P. Serruys, S. Garg, S. Windecker, 2021, European heart journal. Cardiovascular pharmacotherapy.

Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial.

P. Serruys, J. Wykrzykowska, P. Jüni, 2020, European heart journal. Cardiovascular pharmacotherapy.

Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events

V. Ribeiro, D. van Klaveren, P. Serruys, 2020, Circulation. Cardiovascular quality and outcomes.

The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, Atherosclerosis.

Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease

P. Serruys, V. Fuster, F. Burzotta, 2021, European heart journal.

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

P. Serruys, S. Garg, S. Windecker, 2020, Cardiovascular Diabetology.

Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease

P. Serruys, S. Garg, R. V. van Geuns, 2021, Clinical Research in Cardiology.

Regional variation in patients and outcomes in the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, International journal of cardiology.

‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Windecker, 2021, European heart journal. Acute cardiovascular care.

Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Garg, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, Clinical Research in Cardiology.

The impact of heart rate circadian rhythm on in-hospital mortality in stroke and critically ill patients: insights from the eICU Collaborative Research Database.

Xueqin He, Zhe Li, X. Xie, 2022, Heart rhythm.

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

J. J. Piek, Deepak L. Bhatt, P. Serruys, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, The American journal of cardiology.

Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, International journal of cardiology.

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Thrombosis and Haemostasis.

Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.

P. Serruys, S. Garg, R. Geuns, 2020, The Canadian journal of cardiology.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

P. Serruys, S. Garg, S. Windecker, 2020, Clinical Research in Cardiology.

Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.

P. Serruys, P. Jüni, S. Windecker, 2019, European heart journal. Cardiovascular pharmacotherapy.

Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease

M. Mack, P. Serruys, F. Mohr, 2021, European heart journal.

Current perspectives on bioresorbable scaffolds in coronary intervention and other fields

P. Serruys, Xinlei Wu, W. Wijns, 2021, Expert review of medical devices.

Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization.

P. Serruys, F. Mohr, F. Burzotta, 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease

V. Fuster, P. Serruys, S. Garg, 2021, Journal of the American College of Cardiology.

Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease

M. Mack, P. Serruys, R. D. de Winter, 2021, Circulation.

Angiography-Based 4-Dimensional Superficial Wall Strain and Stress: A New Diagnostic Tool in the Catheterization Laboratory

J. Reiber, P. Serruys, Xinlei Wu, 2021, Frontiers in Cardiovascular Medicine.

A Randomized Comparison of the Healing Response Between the Firehawk Stent and the Xience Stent in Patients With ST-Segment Elevation Myocardial Infarction at 6 Months of Follow-Up (TARGET STEMI OCT China Trial): An Optical Coherence Tomography Study

Fei Li, Shaoliang Chen, Chao Gao, 2022, Frontiers in Cardiovascular Medicine.

The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX.

P. Serruys, R. D. de Winter, R. V. van Geuns, 2020, Future Cardiology.

The state-of-the-art coronary stent with crystallized sirolimus: the MiStent technology and its clinical program.

P. Serruys, Xinlei Wu, J. Wykrzykowska, 2020, Future cardiology.

The Feasibility and Long-Term Outcomes of the Crossboss/Stingray for Treating Coronary Chronic Total Occlusions Lesions with Distal Diffuse Disease Landing Zone.

Chao Gao, Rutao Wang, Haokao Gao, 2022, Reviews in cardiovascular medicine.

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.

P. Serruys, R. D. de Winter, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials

P. Serruys, S. Garg, R. V. van Geuns, 2021, Circulation. Cardiovascular quality and outcomes.

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.

P. Serruys, J. Wykrzykowska, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mortality after multivessel revascularisation involving the proximal left anterior descending artery

M. Mack, P. Serruys, F. Mohr, 2022, Heart.

Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial.

P. Serruys, R. D. de Winter, A. Zaman, 2021, Circulation. Cardiovascular interventions.

Impact of left ventricular ejection fraction on 10-year mortality in the SYNTAX trial.

P. Serruys, S. Garg, D. Holmes, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Circulation. Cardiovascular interventions.

Quantitative Angiographic Assessment of Aortic Regurgitation After Transcatheter Implantation of the Venus A-valve: Comparison with Other Self-Expanding Valves and Impact of a Learning Curve in a Single Chinese Center

P. Serruys, H. Kawashima, Y. Onuma, 2021, Global heart.

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

C. Terkelsen, P. Serruys, R. D. de Winter, 2023, Frontiers in cardiovascular medicine.

Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry

F. Chen, Yundai Chen, Yaojun Zhang, 2021, BMC Cardiovascular Disorders.

Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease

J. Spertus, P. Serruys, J. Wykrzykowska, 2022, European heart journal. Quality of care & clinical outcomes.

A novel biodegradable polymer-coated sirolimus-eluting stent: 1-year results of the HELIOS registry

Chang Chen, Rutao Wang, Bo Zheng, 2023, Chinese medical journal.

A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial.

J. Reiber, P. Serruys, A. Zaman, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.